Feed CLBT
CL

Cellebrite DI Ltd. CLBT · NASDAQ

$11.79 +2.52% (+$0.29)

Market cap
$2.96B
Enterprise value
$2.85B
P/E
50.4x
Forward P/E
43.0x
PEG
-
P/S
5.8x
P/FCF
21.2x
EV/EBITDA
25.0x
ROIC
6.9%
Gross margin
83.0%
Net margin
11.4%
Dividend yield
-
Payout ratio
-
Net debt/EBITDA
-1.0x
Beta
1.13
Free float
50.0%

About the company

Cellebrite DI Ltd. (CLBT) is an Israeli technology company specializing in digital intelligence and forensic analysis. The company provides advanced tools and solutions for extracting, analyzing, and managing digital data, assisting law enforcement agencies, government organizations, and businesses in obtaining valuable insights from digital devices. Cellebrite is renowned for its cutting-edge technologies that enable swift and effective investigations of cybercrimes, fraud, and other digital threats. The company focuses on innovation and the continuous development of its products to meet the needs of its clients. Cellebrite DI Ltd. (CLBT) shares could be suitable for investors looking for opportunities in cybersecurity and digital forensic analysis.

Sector

Technology

Industry

Software - Infrastructure

CEO

Shiv Ramji

Employees

1,285

Headquarters

Petah Tikva

Valuation

Is today's price reasonable?

Growth and estimates

Is it growing, and what comes next?

Profitability and quality

How much of the revenue is left, and how well does the company use its capital?

Financial health

Can it carry its debt?

Capital and dividends

What does the company do with the money it earns?

Analysts

What do the professionals think, and is it changing?

Owners and insiders

Who holds the stock, and what is management doing?

Segments

Which part of the company is growing?

Peer comparison

How does it compare with similar companies?

Price and risk

How does the stock behave?

Statements

Every number

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy